FDA 483 - Francesco Muntoni, M.D. - May 03, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 was issued to Francesco Muntoni, M.D., a clinical investigator in London, United Kingdom, following an inspection related to a clinical trial for Duchenne Muscular Dystrophy. The inspection revealed significant deviations from the investigational plan, including improper timing of muscle biopsies, unblinding of study drug information, and incorrect subject dosing. Additionally, the firm failed to maintain adequate and accurate case histories, specifically regarding documentation for muscle biopsy sample shipments.
ID · 68e8299e-57d0-4ead-9c9b-f3529fadae7f